What is the best approach for managing chronic wounds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Chronic Wounds

The best approach for managing chronic wounds involves five basic principles: offloading of plantar ulcerations, debridement of necrotic tissue, revascularization when necessary, management of infection, and use of physiologic topical dressings. 1

Initial Management Strategy

  • Offloading of plantar ulcerations is essential to reduce pressure on the wound site and promote healing 1
  • Debridement of necrotic, nonviable tissue converts a biologically chronic wound to an acute wound, accelerating the healing process 1
  • Revascularization of ischemic wounds should be performed when necessary to improve blood supply to the affected area 1
  • Management of infection (both soft tissue and bone) through appropriate antimicrobial therapy is crucial for wound healing 1
  • Use of physiologic, topical dressings to maintain a moist wound environment while controlling exudate 1

Advanced Wound Therapy

When to consider advanced wound therapy:

  • If a wound fails to show at least 50% reduction after 4 weeks of appropriate standard wound management 1
  • Treatment of chronic wounds is best managed in a multidisciplinary/interprofessional setting 1

Advanced wound therapy options include:

  1. Negative-pressure wound therapy

    • Especially useful for deep, large wounds and in preparation for skin grafts 1
    • Available in electrically powered and mechanically powered forms 1
  2. Oxygen therapies

    • Topical oxygen therapy has shown efficacy in healing chronic diabetic foot ulcers at 12 weeks 1
    • Home-based therapy with high participation and few adverse events 1
    • Hyperbaric oxygen therapy may be considered for nonhealing diabetic foot ulcers after revascularization 1
  3. Growth factors

    • Becaplermin (platelet-derived growth factor) promotes chemotactic recruitment and proliferation of cells involved in wound repair 2
    • FDA-approved for diabetic lower extremity ulcers but lacks efficacy in pressure ulcers and venous stasis ulcers 2
  4. Biophysical modalities

    • Include electrical stimulation, ultrasound, and extracorporeal shock wave therapy 1
    • Most supporting studies are retrospective observational or poor-quality RCTs 1
  5. Acellular matrix tissues and bioengineered cellular therapies

    • Commonly used for more superficial ulcerations 1
    • Include xenograft dermis, human dermis products, and bilayered skin equivalents 1

Special Considerations

  • For diabetic foot ulcers (DFUs):

    • Proper pressure offloading is critical 1
    • After healing, patients should be enrolled in a formal comprehensive prevention program to reduce recurrence 1
  • For venous leg ulcers (VLUs):

    • Adjunctive techniques like split-thickness skin grafting and cellular therapy should only be considered after 4-6 weeks of standard therapy failure 1
    • Surgical debridement helps convert chronic wounds to acute wounds 1

Common Pitfalls to Avoid

  • Failing to reassess underlying pathology when wounds don't improve after 4 weeks 3
  • Using advanced therapies without first addressing the five basic principles of wound care 1
  • Overlooking the importance of treating the underlying cause of the chronic wound 4
  • Using topical antimicrobial dressings without clear indication, as they have shown no benefit in venous ulcers 1
  • Neglecting to evaluate for osteomyelitis in non-healing ulcers 1

Evidence Quality Considerations

  • Evidence to support advanced wound therapy is challenging to produce and assess due to:

    • Difficulty in randomization of trial participants 1
    • Exclusion of certain cohorts (e.g., individuals with chronic renal disease) from RCTs 1
    • Challenges in blinding participants and clinicians 1
  • Products or agents with robust RCTs or systematic reviews should generally be preferred over those without level 1 evidence 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Challenges in the Treatment of Chronic Wounds.

Advances in wound care, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.